Scientific Reports · 2017 · 44 citations · 37 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryOrganic ChemistryStructure-activity RelationshipsEnzyme InhibitionMedicinal PlantsNatural Product Drug DiscoveryStructure-activity Relationship AnalysisMedicinal Chemistry ApplicationsPharmacological ScreeningPhosphodiesterase-4 Inhibitors
Abstract Bioassay-guided fractionation of the ethanolic extract of the leaves of Psidium guajava led to the isolation of 11 new Psidium meroterpenoids, psiguajadials A–K ( 1 – 11 ), along with 17 known ones ( 12 – 28 ). Their structures and absolute configurations were elucidated by spectroscopic methods and comparison of experimental and calculated ECD. Compounds 1 and 2 represent two unprecedented skeletons of 3,5-diformyl-benzyl phloroglucinol-coupled sesquiterpenoid, while 3 is the first example of Psidium meroterpenoids coupling via an oxepane ring. Putative biosynthetic pathways towards 1 and 2 are proposed. Compounds 1 – 13 and 16 – 26 exhibited moderate inhibitory activities against phosphodiesterase-4 (PDE4), a drug target for asthma and chronic obstructive pulmonary disease, with IC 50 values in the range of 1.34–7.26 μ M.
37
A Short Biomimetic Synthesis of the Meroterpenoids Guajadial and Psidial A
Andrew L. Lawrence, Robert M. Adlington, Jack E. Baldwin et al. · Organic Letters · 2010 · 126 citations
Pharmacy, Biochemistry, Chemistry +11
Macrocarpals: HIV-RTase inhibitors of Eucalyptus globulus
Mugio Nishizawa, Makoto Emura, Yukiko Kan et al. · Tetrahedron Letters · 1992 · 100 citations